Vimarsana
Biggest News Aggregation in the World

Page 2 - Arcview Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Arcview Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Arcview Group Today - Breaking & Trending Today

EXCLUSIVE: NY Cannabis Market Optimism Prevails Despite 'Absurd' Taxes, Illegal Operators, Lawsuits - Curaleaf Holdings (OTC:CURLF), Acreage Holdings (OTC:ACRHF), Green Thumb Industries (OTC:GTBIF) - Vimarsana News

EXCLUSIVE: NY Cannabis Market Optimism Prevails Despite 'Absurd' Taxes, Illegal Operators, Lawsuits - Curaleaf Holdings (OTC:CURLF), Acreage Holdings (OTC:ACRHF), Green Thumb Industries (OTC:GTBIF)

Ever since the launch of the legal cannabis market in New York last year, the industry has been dealing with one setback after another.

ArcStone Securities To Acquire Arcview Capital, Betting Big On Cannabis Industry - Vimarsana News

ArcStone Securities To Acquire Arcview Capital, Betting Big On Cannabis Industry

ArcStone Securities & Investments Corp. has officially unveiled plans to acquire the New York-based, FINRA-registered broker-dealer Arcview Capital LLC.

ArcStone Securities To Acquire Arcview Capital, Betting Big On Cannabis Industry - Vimarsana News

ArcStone Securities To Acquire Arcview Capital, Betting Big On Cannabis Industry

ArcStone Securities & Investments Corp. has officially unveiled plans to acquire the New York-based, FINRA-registered broker-dealer Arcview Capital LLC.

CT cannabis startups seek investor funding to launch - Vimarsana News

CT cannabis startups seek investor funding to launch

The presenters recently completed a 10-month business accelerator program. Now, they've secured licenses and are 'actively raising capital.'

Exclusive: FloraWorks Completes $2.25M Series-A Financing For Cannabinoid Research - Vimarsana News

Exclusive: FloraWorks Completes $2.25M Series-A Financing For Cannabinoid Research

FloraWorks, a cannabinoid therapeutics company specializing in rare and novel cannabinoids, has successfully completed a $2.25 million Series-A financing round. Leading this significant investment was life sciences venture capital firm, Bonaventure Equity LLC.